Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 1/6/25 → 1/6/27 |
Funding
- Ionis Pharmaceuticals Incorporated: $14,811.00
A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacokinetics of ION269 in Adults with Down Syndrome
- Coskun, Elif (PI)